Tibion is developing equipment that can help individuals recover physical function lost due to disease, trauma or aging. Its first commercialized product, the Tibion Bionic Leg, actively assists therapists with the rehabilitation of individuals who present with lower extremity dysfunction that impairs function, mobility and gait. Primary candidates for the Tibion Bionic Leg include individuals disabled by stroke, and certain neurologic degenerative diseases such as multiple sclerosis. In June 2013, Tibion was acquired by AlterG. The valuation of Tibion was undisclosed. Other terms of the deal were not released.
Missing: Tibion's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Tibion's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Tibion has filed 8 patents.
Vascular diseases, Hematology, Coagulopathies, Inflammations, Syndromes
Vascular diseases, Hematology, Coagulopathies, Inflammations, Syndromes
Latest Tibion News
Jun 27, 2013
Revolutionary fitness and rehabilitation company expands product portfolio with AlterG Bionic Leg™ PRLog - June 26, 2013 - FREMONT, Calif. -- AlterG™, the revolutionary training and rehabilitation company that launched the first Anti-Gravity Treadmill, today announced the acquisition of Tibion, creator of the first wearable bionic leg. “We are building a world-class portfolio of the most innovative and important rehabilitation tools available to the medical and fitness markets,” said AlterG CEO Steve Basta. “The addition of the Bionic Leg continues our efforts to help people rehab quickly, safely and effectively.” The AlterG Bionic Leg is a wearable, battery-powered, robotic mobility assistance device activated by the patient’s intent to move. Used by physical therapists for patients with impaired mobility, the AlterG Bionic Leg strengthens stance, improves gait, and enhances active motor learning while protecting its user. Currently, the apparatus is a crucial component for stroke rehabilitation and therapy for patients with chronic, degenerative neurological gait impairment including Parkinson’s disease and Multiple Sclerosis (MS). The Bionic Leg has also been demonstrated to be of high value in rehabilitation therapy for orthopedic injury. The apparatus specifically provides assistance needed to participate more actively in sit-to-stand, overground walking and stair climbing exercises that are critical to the recovery of gait and balance. When a patient begins to stand up or ascend a stair, the software’s sensors detect the weight shift and the knee angle changes, and then the device applies assistive force in leg extension to help lift the patient. When the patient wants to sit down or descend stairs, the device applies a resistance force to provide controlled descent. While walking, the device allows the leg to move freely during the swing phase, while providing added support during the stance phase. The Bionic Leg can be used to provide physical support and therapy across markets where patients suffer with mobility impairment and gait deficits. The acquisition of Tibion by AlterG will provide additional resources to grow Bionic Leg placements and increase production, expanding its availability worldwide. “I am excited by the new opportunities that will result from the recent acquisition of Tibion by AlterG,” said, Dr. Robert Horst, the inventor of the Bionic Leg and the Chief Technology Officer of Robotics at AlterG. “The additional resources in manufacturing, sales and engineering will allow us to ramp production and make Bionic Leg therapy available to a much larger population of patients throughout the world.” The AlterG Bionic Leg is currently available in over 100 hospitals, physical therapy facilities and skilled nursing facilities worldwide. The AlterG Bionic Leg was the recipient of the 9th annual Invention and Entrepreneurship Award in Robotics and Automation (IERA) during the 2013 International Conference on Robotics and Automation in Karlsruhe, Germany. For more information on AlterG, please visit http://www.alterg.com . For more information on AlterG Bionic Leg, please visit http://www.tibion.com . About AlterG AlterG, Inc. is revolutionizing modern rehabilitation through the use of the cutting edge Anti-Gravity Treadmill® and Bionic Leg. The AlterG Bionic Leg™ is a wearable, battery-powered, robotic mobility assistance device activated by a patient’s intent to move. The Bionic Leg is currently available in over 100 hospitals, physical therapy facilities and skilled nursing facilities worldwide. The AlterG Anti-Gravity Treadmill® technology was originally developed for NASA and is the first FDA-cleared medical device that uses patented differential air pressure technology. AlterG products are used by major medical centers, leading physical therapy clinics, top professional and collegiate teams and athletes, and individual sports and fitness programs worldwide. --- End ---
Tibion Frequently Asked Questions (FAQ)
When was Tibion founded?
Tibion was founded in 2002.
Where is Tibion's headquarters?
Tibion's headquarters is located at 247 Santa Ana Court, Sunnyvale.
What is Tibion's latest funding round?
Tibion's latest funding round is Acquired.
How much did Tibion raise?
Tibion raised a total of $18.41M.
Who are the investors of Tibion?
Investors of Tibion include AlterG, Three Arch Partners, Tekla Capital Management, Claremont Creek Ventures and Saratoga Ventures.
Who are Tibion's competitors?
Competitors of Tibion include NeoChord, Bioness, LifeBond, Viveve Medical, Blue Belt Technologies and 16 more.
Compare Tibion to Competitors
Healionics develops and manufactures STAR Biomaterials for implanted medical devices. The precisely controlled pore structure of the STAR technology induces an integrated healing response, overcoming fibrotic reactions and infection issues to enhance medical device performance and longevity.
IN2BATE is prepared to enter the emergency medicine market by offering a cricothyroidotomy device. A cricothyroidotomy is an emergency procedure that is performed on patients suffering from an obstructed airway, usually caused by a trauma accident. Thorough market research has allowed for us to create a strategic advantage over the competition by creating a solution for an uncontested market space. The company's target market includes hospitals--specifically emergency departments, ambulance service companies, ambulance supply companies, and emergency response units.
L.I.T. Surgical (formerly known as Alpha Med-Surge) is a medical device company that has developed a patent-protected, head-mounted surgical headlight that surpasses the current industry standard to meet the critical needs of surgeons throughout the world. The L.I.T. Surgical design aims to deliver a cooler, brighter light through the combination and collection of light from multiple LEDs, and the direction of that light through sophisticated optical geometry. This results in a highly efficient "white light" that aims to enable the user to view the working field and identify structures with unparalleled clarity and definition.
The resources necessary to transform a medical device concept into a commercially viable reality are enormous. Appropriate funding in addition to Food and Drug Administration ( FDA) experience, engineering and rapid prototyping are essential in order to have any reasonable chance for success. To this end, SpringMed Group is a medical device business accelerator that has been designed and organized around core competencies that will substantially improve the development time line and successful launch of new and medical devices.
NeuroTrax is a medical device and technology company.
Otothera Corporation is a medical device company developing products to diagnose and treat the more than seven million severe tinnitus (constant ringing in the ears) sufferers in the US. The company was originally named AudioFusion. The company was a 2006 PTEN Growth Accelerator (GAP) winner.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.